Literature DB >> 21326932

Probiotics and pharmabiotics: alternative medicine or an evidence-based alternative?

Colin Hill1.   

Abstract

That commensal bacteria play an important role in human health is beyond doubt, and it is now widely accepted that humans function as super organisms, whose collective metabolic potential exceeds the sum of our individual eukaryotic and prokaryotic components. However, while it is has been established that the prokaryotic component of the human superorganism is amenable to manipulation by chemotherapeutic, dietary or microbial interventions, the significance of such alterations in terms of human health or well being is less well established. Prebiotics (non- digestible food ingredients that stimulate the growth and/or activity of bacteria in the digestive system) and probiotics (live microorganisms that when administered in adequate amounts, confer a health benefit on the host) are often bracketed among 'alternative' approaches to influencing human health, such as homeopathy, naturopathy, acupuncture and hypnotherapy. Others believe that prebiotics and probiotics have proven their effectiveness in properly conducted, clinically controlled human trials and therefore can be considered as evidence-based alternatives or adjuncts to conventional medicines. My journey from a position of total skepticism to 'reluctant convert' is the basis of this article, which should not be considered in any sense as a review of the literature but simply a personal account of this transition. While I am not bent on converting other doubters, I will recount some of the thought processes and evidence that has helped to form my current opinion.
© 2010 Landes Bioscience

Entities:  

Keywords:  bacteriocins; commensals; infection; microbiota; pharmabiotic; probiotics

Mesh:

Year:  2009        PMID: 21326932      PMCID: PMC3026447          DOI: 10.4161/bbug.1.2.10796

Source DB:  PubMed          Journal:  Bioeng Bugs        ISSN: 1949-1018


  17 in total

1.  Biography of Todd R. Klaenhammer.

Authors:  Emma Hitt
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

Review 2.  The gut flora as a forgotten organ.

Authors:  Ann M O'Hara; Fergus Shanahan
Journal:  EMBO Rep       Date:  2006-07       Impact factor: 8.807

3.  The lantibiotic lacticin 3147 produced in a milk-based medium improves the efficacy of a bismuth-based teat seal in cattle deliberately infected with Staphylococcus aureus.

Authors:  Fiona Crispie; Denis Twomey; James Flynn; Colin Hill; Paul Ross; William Meaney
Journal:  J Dairy Res       Date:  2005-05       Impact factor: 1.904

4.  Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

Authors:  L Steidler; W Hans; L Schotte; S Neirynck; F Obermeier; W Falk; W Fiers; E Remaut
Journal:  Science       Date:  2000-08-25       Impact factor: 47.728

5.  A five-strain probiotic combination reduces pathogen shedding and alleviates disease signs in pigs challenged with Salmonella enterica Serovar Typhimurium.

Authors:  Pat G Casey; Gillian E Gardiner; Garrett Casey; Bernard Bradshaw; Peadar G Lawlor; P Brendan Lynch; Finola C Leonard; Catherine Stanton; R Paul Ross; Gerald F Fitzgerald; Colin Hill
Journal:  Appl Environ Microbiol       Date:  2007-01-19       Impact factor: 4.792

6.  Metagenomic analysis of the human distal gut microbiome.

Authors:  Steven R Gill; Mihai Pop; Robert T Deboy; Paul B Eckburg; Peter J Turnbaugh; Buck S Samuel; Jeffrey I Gordon; David A Relman; Claire M Fraser-Liggett; Karen E Nelson
Journal:  Science       Date:  2006-06-02       Impact factor: 47.728

7.  Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome.

Authors:  Peter J Whorwell; Linda Altringer; Jorge Morel; Yvonne Bond; Duane Charbonneau; Liam O'Mahony; Barry Kiely; Fergus Shanahan; Eamonn M M Quigley
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

8.  Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118.

Authors:  Sinéad C Corr; Yin Li; Christian U Riedel; Paul W O'Toole; Colin Hill; Cormac G M Gahan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-24       Impact factor: 11.205

9.  Heterologous expression of BetL, a betaine uptake system, enhances the stress tolerance of Lactobacillus salivarius UCC118.

Authors:  Vivien M Sheehan; Roy D Sleator; Gerald F Fitzgerald; Colin Hill
Journal:  Appl Environ Microbiol       Date:  2006-03       Impact factor: 4.792

10.  Improving gastric transit, gastrointestinal persistence and therapeutic efficacy of the probiotic strain Bifidobacterium breve UCC2003.

Authors:  Vivien M Sheehan; Roy D Sleator; Colin Hill; Gerald F Fitzgerald
Journal:  Microbiology       Date:  2007-10       Impact factor: 2.777

View more
  4 in total

Review 1.  Probiotics in human health and disease: from nutribiotics to pharmabiotics.

Authors:  Eun-Sook Lee; Eun-Ji Song; Young-Do Nam; So-Young Lee
Journal:  J Microbiol       Date:  2018-10-24       Impact factor: 3.422

2.  From biocontrol to cancer, probiotics and beyond.

Authors:  Colum Dunne
Journal:  Bioengineered       Date:  2012-12-17       Impact factor: 3.269

3.  Probiotics: from bench to market.

Authors:  Marguerite Klein; Mary Ellen Sanders; Tri Duong; Howard A Young
Journal:  Ann N Y Acad Sci       Date:  2010-11       Impact factor: 5.691

4.  Lactobacilli: Legal Regulation and Prospects for New Generation Drugs.

Authors:  R A Yunes; E U Poluektova; T V Belkina; V N Danilenko
Journal:  Appl Biochem Microbiol       Date:  2022-09-22       Impact factor: 1.065

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.